A Study of Boniva (Ibandronate) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Post-Menopausal Osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2010
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Planned initiation date (1 Aug 2004) added as reported by Roche record.
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 09 Feb 2006 New trial record.